Company: MIRA
Filing Date: 2025-08-08
Form Type: DEFM14A
Source: 0001641172-25-022816
Chunk: 3

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-08-08
Form: DEFM14A
Chunk 3
---
 current business of MIRA, that the stockholders of MIRA vote “ FOR” Proposal Nos. 1, 2, 3, 4 and 5. More information about MIRA, SKNY and the proposed transaction is contained in the accompanying proxy statement. MIRA urges you to read the accompanying proxy statement carefully and in its entirety. IN PARTICULAR, YOU SHOULD CAREFULLY CONSIDER THE MATTERS DISCUSSED UNDER “ RISK FACTORS” BEGINNING ON PAGE 12.

As
permitted by the “Notice and Access” rules of the Securities and Exchange Commission, we are making this notice and the accompanying
proxy statement, proxy card and 2025 Annual Report available to stockholders electronically via the Internet at the following website:
https://www.astproxyportal.com/ast/27484.

MIRA is excited about the opportunities the Merger brings to its stockholders, and thanks you for your consideration and continued support.

Sincerely,

| /s/ Erez              
 Aminov                |
| Erez                  
 Aminov                |
| Chief                 
 Executive Officer     |
| MIRA                  
 Pharmaceuticals, Inc. |
| August                
 8, 2025               |

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved the Merger described in this proxy statement or the MIRA Common Stock to be issued in connection with the Merger or passed upon the adequacy or accuracy of this proxy statement.

The accompanying proxy statement is dated August 8, 2025, and, together with the enclosed form of proxy card, is first being mailed to MIRA stockholders on or about August 12, 2025.

<div align='center'>MIRA PHARMACUTICALS, INC.

1200 Brickell Avenue, Suite 1950 #1183 Miami, Florida 33131 (786) 432-9792

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON SEPTEMBER 11, 2025

Dear Stockholder of MIRA:</div>

On behalf of the board of directors of MIRA Pharmaceuticals, Inc., a Florida corporation (“MIRA”), we are pleased to deliver this proxy statement for a virtual annual meeting of stockholders of MIRA (the “MIRA virtual annual meeting”).

Notice is hereby given that the MIRA virtual annual meeting will be held on September 11, 2025, at 10:00 A.M. Eastern Time. To facilitate stockholder participation in